The European Commission, which has negotiated pre-orders for anti-Covid vaccines on behalf of the Twenty-Seven, has been hit by heavy fire of criticism following delays in the vaccination campaign.

How to explain such a situation?

Europe 1 takes stock.

DECRYPTION

"I fully support the European approach that we have had."

Emmanuel Macron and Angela Merkel supported the European vaccine strategy on Friday, during a joint press conference.

However, between the delays in deliveries, the standoff with the laboratories, and the lengthening vaccination delays, there are many criticisms against the European Commission, which has negotiated the pre-orders of anti-Covid vaccines in France. name of the Twenty-Seven.

While Europe currently has a lower vaccination record than that of the United Kingdom, how to explain such a delay?

Europe 1 takes stock.

>> LIVE - 

Coronavirus: follow the evolution of the situation on Saturday January 6

Precautions taken by the European Union ...

First there were deliberate choices, and assumed: unlike the United Kingdom or Israel, Europeans have negotiated with laboratories so that they are legally responsible for the side effects of vaccines.

A precaution which was not taken elsewhere, but which took time.

Likewise, Jerusalem has agreed to communicate the medical data of its citizens to laboratories, unlike Europe.

Finally, the 27 wanted to wait for a full review by the European Medicines Agency before authorizing vaccines to circulate on the territory, while elsewhere the authorizations were issued urgently.

CORONAVIRUS ESSENTIALS

> The English variant would cause slightly different symptoms

> Not recommended for people over 65, who will be injected with the AstraZeneca vaccine? 

> Audio, webcams ... When technology adapts to teleworking

> Containment is good for the planet

> How will the vaccination passport work in Denmark?

... and errors

But there are also European errors.

For example, the 27 fought for the lowest possible price for doses, while the cost of the epidemic makes these efforts a little paltry.

And finally, the President of the European Commission, Ursula von der Leyen, herself admitted: Brussels and the capitals have underestimated the challenges of industrial mass production of vaccines.

Friday, Emmanuel Macron for his part admitted that the Europeans had "not anticipated" the "so rapid success on messenger RNA vaccines".